BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $4354.20.64 only $1741.68

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.87
0.44%
US Tech 100
20,240.00
-0.65%
S&P 500
5,998.74
-0.38%
US Dollar vs CAD
1.40069
-0.14%
Bitcoin
94,900.96
-1.12%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Celadon Pharmaceuticals Plc (CEL)

  7. Celadon Pharmaceuticals Plc (CEL) Financials

Celadon Pharmaceuticals Plc

Celadon Pharmaceuticals Plc (CEL)

Challenger Gold Limited
12.50
0.00
(0.00%)
Closed November 28 10:30AM
Delayed by 15 minutes

Statistics

Year End December 30 2023 20192020202120222023
GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)
Return on Assets (%) -6.744-3.136-11.895-171.267-63.546
Return on Equity (%) -6.784-3.157-12.134-252.915-139.753
Return on Invested Capital (%) -7.317-3.373-12.168-174.752-106.378
Operating Margin (%) N/A N/A N/A -53925-9233.333
Net Profit Margin (%) N/A N/A N/A -70858.333-9520
Book Value Per Share 91.98979.810.74.4
Earnings Per Share -3.1-2.9-9-27.6-11.1
Cash Per Share 92.189.555.68.22
Working Capital Per Share 92.189.280.18.32.4
Operating Profit Per Share N/A N/A N/A -0.10.1
EBIT Per Share -3.1-2.9-9-29.4-11.7
EBITDA Per Share -3.1-2.9-9-29.4-11.7
Free Cash Flow Per Share -3.1-2.9-9-24.9-11.4

Liquidity Ratios

Year End December 30 2023 20192020202120222023
Current Ratio N/A N/A N/A N/A N/A
Quick Ratio N/A N/A N/A N/A N/A
Inventory Turnover (Days) N/A N/A N/A N/A N/A
Shares Outstanding 6.13M6.13M8.03M61.67M64.21M

Key Stats and Ratios

Market Cap 8.28M
Price to Earnings Ratio -1.16
Price to Sales Ratio 54.35
Price to Cash Ratio 6.58
Price to Book Ratio 2.6
Dividend Yield -

Share Statistics

Shares Outstanding 66.22M
Average Volume (1 week) 92.41k
Average Volume (1 Month) 90.72k
52 Week Change -88.53%
52 Week High 127.50
52 Week Low 12.50
More Ratios Coming Soon!

Your Recent History

LSE
CEL
Celadon Pharmaceuticals
BIT
UC2XUZ
Unicredit Bank
BIT
UC7A8K
Unicredit Bank
BIT
UB30F9
UniCredit Bank
BIT
UR9ZNB
UniCredit Bank
BIT
UB3ZDZ
Unicredit Bank
BIT
UB3ZE5
Unicredit Bank
BOV
ARZZ3M
AREZZO ON
BIT
S27832
Societe Generale Effekten
BIT
UC7V32
Unicredit Bank
BIT
UC4VDM
Unicredit Bank
BIT
UV8B4H
UniCredit Bank
BIT
F32115
Vontobel Financial Produ...
BIT
DIS
D Amico International Sh...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Canadian Securities Exchange (CSE) Level 1 and 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $738.72 only $295.49